chr16-56885307-T-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_001126108.2(SLC12A3):āc.1868T>Cā(p.Leu623Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000855 in 1,403,690 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 0.0000085 ( 0 hom. )
Consequence
SLC12A3
NM_001126108.2 missense
NM_001126108.2 missense
Scores
4
8
7
Clinical Significance
Conservation
PhyloP100: 4.91
Genes affected
SLC12A3 (HGNC:10912): (solute carrier family 12 member 3) This gene encodes a renal thiazide-sensitive sodium-chloride cotransporter that is important for electrolyte homeostasis. This cotransporter mediates sodium and chloride reabsorption in the distal convoluted tubule. Mutations in this gene cause Gitelman syndrome, a disease similar to Bartter's syndrome, that is characterized by hypokalemic alkalosis combined with hypomagnesemia, low urinary calcium, and increased renin activity associated with normal blood pressure. This cotransporter is the target for thiazide diuretics that are used for treating high blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.93
PP5
Variant 16-56885307-T-C is Pathogenic according to our data. Variant chr16-56885307-T-C is described in ClinVar as [Pathogenic]. Clinvar id is 8595.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC12A3 | NM_001126108.2 | c.1868T>C | p.Leu623Pro | missense_variant | 15/26 | ENST00000563236.6 | NP_001119580.2 | |
SLC12A3 | NM_000339.3 | c.1868T>C | p.Leu623Pro | missense_variant | 15/26 | NP_000330.3 | ||
SLC12A3 | NM_001126107.2 | c.1865T>C | p.Leu622Pro | missense_variant | 15/26 | NP_001119579.2 | ||
SLC12A3 | NM_001410896.1 | c.1865T>C | p.Leu622Pro | missense_variant | 15/26 | NP_001397825.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC12A3 | ENST00000563236.6 | c.1868T>C | p.Leu623Pro | missense_variant | 15/26 | 1 | NM_001126108.2 | ENSP00000456149 | A1 | |
SLC12A3 | ENST00000438926.6 | c.1868T>C | p.Leu623Pro | missense_variant | 15/26 | 1 | ENSP00000402152 | A1 | ||
SLC12A3 | ENST00000566786.5 | c.1865T>C | p.Leu622Pro | missense_variant | 15/26 | 1 | ENSP00000457552 | P4 | ||
SLC12A3 | ENST00000262502.5 | c.1865T>C | p.Leu622Pro | missense_variant | 15/26 | 5 | ENSP00000262502 | A1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000613 AC: 1AN: 163202Hom.: 0 AF XY: 0.0000116 AC XY: 1AN XY: 86188
GnomAD3 exomes
AF:
AC:
1
AN:
163202
Hom.:
AF XY:
AC XY:
1
AN XY:
86188
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000855 AC: 12AN: 1403690Hom.: 0 Cov.: 30 AF XY: 0.0000101 AC XY: 7AN XY: 692816
GnomAD4 exome
AF:
AC:
12
AN:
1403690
Hom.:
Cov.:
30
AF XY:
AC XY:
7
AN XY:
692816
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Familial hypokalemia-hypomagnesemia Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 26, 2023 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 1996 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 18, 2023 | Variant summary: SLC12A3 c.1868T>C (p.Leu623Pro) results in a non-conservative amino acid change located in the Amino acid permease/ SLC12A domain (IPR004841) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 6.1e-06 in 163202 control chromosomes (gnomAD). c.1868T>C has been reported in the literature in multiple individuals affected with Familial Hypokalemia-Hypomagnesemia with evidence of cosegregation with disease (Takeuchi_1996, Riveira-Munoz_2007, Mori_2021), and some patients were reported as compound heterozygous with other (likely) pathogenic or truncating variants. These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 8954067, 17329572, 33348466). One submitter has cited a clinical-significance assessment for this variant to ClinVar after 2014 and has classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 15, 2023 | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SLC12A3 protein function. This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 623 of the SLC12A3 protein (p.Leu623Pro). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with Gitelman syndrome (PMID: 8954067, 12008755, 17044667, 17329572, 30596175). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 8595). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;.;D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;M;.
MutationTaster
Benign
A;A;A;A
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N
REVEL
Benign
Sift
Benign
T;T;T;T
Sift4G
Benign
T;T;T;T
Polyphen
B;B;B;.
Vest4
MutPred
0.83
.;Loss of stability (P = 0.0039);Loss of stability (P = 0.0039);.;
MVP
MPC
0.32
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at